Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am –  Lobby Level

One-to-One Meetings 

8:55 am –  2nd Floor

Welcome Back 

• Sara Jane Demy, Founder & CEO, Demy-Colton 

9:00 am –  2nd Floor

Big Think Fireside Chat 

Rewriting the Narrative of Aging: Progress, Perspectives, and Future of Longevity Science and Healthspan 

• Interviewer: Jeremy Abbate, Publisher, Scientific America
• Interviewees:
  • Maria Carney, Chief, Geriatrics and Palliative Medicine & Medical Director, Northwell Health
  • Tim Opler, Managing Director, Global Healthcare Group, Stifel

10:00 am –  Lobby Level

One-to-One Meetings 

10:00 am –  2nd Floor

Spotlight Panel 4A 

Molecules & Machine Learning: The AI Drug Discovery Frontier 

Moderator:

• Viq Pervaaz, Senior VP, Life Sciences & Healthcare, NYCEDC

Panel:

• Bogdan Knezevic, Co-Founder & CEO, Kaleidoscope.bio
• Akhila Kosaraju, CEO, Phare Bio
• Filipp Kramer, CEO, Alchemy Bio

10:00 am – 12th Floor

Spotlight Panel 4B 

Tomorrow, Today: Showcasing the Next Wave of Bio Breakthroughs

Moderator:

• David Schull, President, Russo Partners

Panel:

• Stacy Blain, CEO & Founder, Concarlo Therapeutics Inc.
• David Pass, CEO, AltrixBio Inc.
• Michael Webb, CEO, Epion Therapeutics, Inc.

11:10 am – 2nd Floor

“Big Think” Plenary Session 

Dealmaking Dynamics: Navigating BD Strategies in a Competitive Biopharma Landscape 

Panel:  

• Nouhad Husseini, Senior VP, BD & Corporate Strategy, Regeneron Pharmaceuticals, Inc. 
• Konstantina Katcheves, Senior VP, Chief Business & Strategy Officer, Acadia Pharmaceuticals
• Arda Ural, Partner, Americas Sector Leader for Life Sciences, Ernst & Young LLP 

12:00 pm – 2nd Floor & Lobby Level 

Lunch

1:15 pm – 2nd Floor

“Big Think" Plenary Session

The Price of Innovation: Navigating the Complex Landscape of Drug Pricing

Moderator:

• Alice Valder Curran, Partner, Global Regulatory, Hogan Lovells

Panel:

• Neal Masia, Co-Founder & CEO, EntityRisk, Inc. 

2:15 pm – Lobby Level

One-to-One Meetings

2:15 pm –  2nd Floor

Dialogue 2A 

New Developments in Cancer: Seeing the Signs 

Moderator: 

• Gregory Simon, Former Director, White House Cancer Moonshot 

Panel: 

• Bhavagaya Bakshi, CEO, C the Signs 
• Roger Hajjar, Director, Gene and Cell Therapy Institute, Mass General Brigham
• Jeffrey Meckler, CEO, Indaptus Therapeutics
• Ashish Tripathi, CEO, Tzar Labs 

2:15 pm –  12th Floor

Dialogue 2B 

Organoids: New Approach Methodologies 

Moderator:  

• Daniella Kranjac, Founding GP, Avant Bio 

Panel:

• Julie Frearson, SVP & CSO, Charles River Laboratories
• Alice Gilman, COO, R3 Biotechnologies 

3:10 pm –  2nd Floor

Dialogue 3A 

The Immunome: Get Ready to Understand the Mother of All Systems 

Moderator:  

• David Ewing Duncan, Author, Journalist & Entrepreneur     

3:10 pm – 12th Floor

Dialogue 3B 

Global Strategy in Transition: Opportunities and Risks in China 

Moderator:

• Michael D. Patten, Chief Strategy Officer, Harbour BioMed

Panel: 

• Raven Lin, CEO & Director, Pilatus Biosciences
• Tim Opler, Managing Director, Global Healthcare Group, Stifel
• Echo Hindle-Yang, Founder & CEO, MSQ Ventures
• Lihua Zheng, Co-Founder & CEO, Z-Star Therapeutics Inc.

4:10 pm – 2nd Floor

End of Day “Big Think" Plenary Session 

AI & Quantum Computing: Revolutionizing Healthcare                                    

Moderator: 

• Beth Rogozinski, CEO, Oncoustics 

Panel: 

• Tala Fakhouri, VP Consulting, AI & Digital Policy, Real-World Research, Parexel 
• Priyanka Rao, Investor, Rackhouse Venture Capital
• MaryAnne Rizk, Managing Director, Head of Healthcare & Lifescience Clinical Strategy, AWS

5:30-7:00 pm

Networking Reception

Barlume Downstairs – 900 Broadway (20th Street)
Sponsored by Russo Partners